about
Treatment of primary pulmonary hypertension intravenous epoprostenol (prostacyclin)Reversibility of primary pulmonary hypertension during six years of treatment with oral diazoxidePharmacotherapy for idiopathic pulmonary arterial hypertension during the past 25 years.Vasodilator responsiveness in idiopathic pulmonary arterial hypertension: identifying a distinct phenotype with distinct physiology and distinct prognosis.Development of Pulmonary Hypertension During Treatment with Diazoxide: A Case Series and Literature Review.Pharmacotherapy of chronic pulmonary arterial hypertension: value and limitations. Part I: Primary pulmonary hypertension.
P2860
description
1981 nî lūn-bûn
@nan
1981 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1981 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
name
Hazards of diazoxide in pulmonary hypertension
@ast
Hazards of diazoxide in pulmonary hypertension
@en
Hazards of diazoxide in pulmonary hypertension
@nl
type
label
Hazards of diazoxide in pulmonary hypertension
@ast
Hazards of diazoxide in pulmonary hypertension
@en
Hazards of diazoxide in pulmonary hypertension
@nl
prefLabel
Hazards of diazoxide in pulmonary hypertension
@ast
Hazards of diazoxide in pulmonary hypertension
@en
Hazards of diazoxide in pulmonary hypertension
@nl
P356
P1476
Hazards of diazoxide in pulmonary hypertension
@en
P2093
P356
10.1136/HRT.46.4.401
P407
P577
1981-10-01T00:00:00Z